0QUD Mainstay Medical International Plc

 
TIDMIRSH 
 
 

Standard Form TR-1

Standard form for notification of major holdings

 
NOTIFICATION 
OF MAJOR 
HOLDINGS(to 
be sent to the 
relevant 
issuerandto 
the 
Central 
Bank 
of Ireland)i 
1. Identity 
of the 
issuer or the 
underlying 
issuer 
of existing 
shares to 
which 
voting 
rights 
are 
attachedii: 
Mainstay 
Medical 
International 
plc 
2. 
Reason 
for 
the 
notification(please 
tick 
the 
appropriate 
box or boxes): 
[x] 
An acquisition 
or disposal 
of voting 
rights 
[ 
] An acquisition 
or disposal 
of financial 
instruments 
[x] An event 
changing 
the breakdown 
of voting 
rights 
[ ] Other 
(please 
specify)iii: 
3. Details 
of person 
subject to 
the 
notification 
obligationiv: 
Name:                                                                       City and country of registered office (if applicable): N/A 
Sofinnova                                                                   18 rue du 4 Septembre 75002, Paris, France 
Capital 
VI FCPR 
4. 
Full 
name 
of 
shareholder(s)(if 
different from 
3.)v:  N/A 
5. Date on 
which 
the threshold 
was crossed 
or 
reachedvi:15 
February 2018 
6. Date on 
which 
issuer 
notified:16 
February 2018 
7. 
Threshold(s) 
that 
is/are crossed 
or 
reached:Below 
32% 
8. 
Total positions 
of 
person(s) 
subject 
to 
the notification 
obligation: 
                      % of voting rights attached to shares (total of 9.A)  % of voting rights through financial instruments  Total of both in % (9.A + 9.B)  Total number of voting rights of issuervii 
                                                                            (total of  9.B.1 + 9.B.2) 
Resulting             27.5%                                                 N/A                                               27.5%                           2,415,813 
situation 
on 
the date 
on which 
threshold was 
crossed 
or  reached 
Position of           32.7%                                                 N/a                                               32.7% 
previous 
notification 
(if 
applicable) 
 
 
9. Notified details of the resulting situation on the date on  which the threshold was crossed or reachedviii: 
A: Voting rights attached to shares 
Class/type of                  Number of voting rightsix                                 % of voting rights 
shares 
ISIN code (if possible) 
                               Direct          Indirect                                  Direct               Indirect 
                               2,415,813       N/A                                       27.5%                N/A 
SUBTOTAL A                     2,415,813                                                 27.5% 
B 1: Financial Instruments according to Regulation 17(1)(a) of  the Regulations 
Type of financial instrument     Expiration  Exercise/                                   Number of voting rights that may be acquired if the instrument is  exercised/converted.                 % of voting rights 
                                 datex       Conversion Periodxi 
N/A                              N/A         N/A                                         N/A                                                                                                      N/A 
                                             SUBTOTAL B.1 
B 2: Financial Instruments with similar economic effect according  to Regulation 17(1)(b) of the Regulations 
Type of financial instrument   Expiration    Exercise/              Physical or cash settlementxii    Number of voting rights                                                                     % of voting rights 
                               datex         Conversion Periodxi 
N/A                            N/A           N/A                    N/A                               N/A                                                                                         N/A 
                                                                    SUBTOTAL B.2 
 
 
10. Information in relation to the person subject to the 
notification obligation(please tick the applicable box): 
 
[x] Person subject to the notification obligation is not  controlled by any natural person or legal entity and does 
not  control any other undertaking(s) holding directly or indirectly an  interest in the (underlying) issuer.xiii 
 
[ ] Full chain of controlled undertakings through  which the voting rights and/or thefinancial  instruments 
are effectively held starting with the ultimate  controlling natural person or legal entityxiv: 
Namexv                                                                                                                % of voting rights if it equals or is higher than the notifiable  threshold % of voting rights through financial instruments if it equals or  is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable  threshold 
11. In case of proxy voting: [name of the proxy holder]  will 
cease to hold [% and number] voting rights as of [date] 
N/A 
12. 
Additional informationxvi: 
Sofinnova Partners SAS, a French corporation ("SP 
SAS"), the  management company of Sofinnova 
Capital VI FCPR, may be deemed to have sole voting 
power, and  Denis Lucquin, Antoine Papiernik and 
Monique Saulnier, the managing partners of SP SAS, 
may be deemed  to have shared power to vote these 
shares. 
 
 

Done at Paris on 16 February 2018.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180219005433/en/

 
This information is provided by Business Wire 
 
 

(END) Dow Jones Newswires

February 19, 2018 12:33 ET (17:33 GMT)

Mainstay Medical (LSE:0QUD)
Historical Stock Chart
From Jun 2024 to Jul 2024

Mainstay Medical (LSE:0QUD)
Historical Stock Chart
From Jul 2023 to Jul 2024